Preparation and Characterization of PLGA-crebanine Nanoparticles and Analysis of Its  Release

CHENG Xin; KONG Shu-jun; WANG Hui; HUANG Qiu-yan; WANG Hong-mei; MA Yun-shu

doi:10.13422/j.cnki.syfjx.20180901

您当前的位置：

首页 >

文章列表页 >

Preparation and Characterization of PLGA-crebanine Nanoparticles and Analysis of Its Release

更新时间：2024-01-04

- Preparation and Characterization of PLGA-crebanine Nanoparticles and Analysis of Its Release
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 9, Pages: 9-14(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20180901
  CLC： R283.6
- Published：2018
- 稿件说明：
移动端阅览
CHENG Xin, KONG Shu-jun, WANG Hui, et al. Preparation and Characterization of PLGA-crebanine Nanoparticles and Analysis of Its Release[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(9): 9-14.
DOI：

CHENG Xin, KONG Shu-jun, WANG Hui, et al. Preparation and Characterization of PLGA-crebanine Nanoparticles and Analysis of Its Release[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(9): 9-14. DOI： 10.13422/j.cnki.syfjx.20180901.

摘要

目的：制备并表征聚乳酸-羟基乙酸共聚物（PLGA）-克班宁纳米粒（PLGA-Cre-NPs），考察其体外释放特性，为克班宁的体内作用时间延长、毒性降低提供参考。方法：以PLGA为载体，采用乳化溶剂扩散法制备PLGA-Cre-NPs。以包封率、粒径、多分散指数（PDI）为评价指标，通过星点设计-效应面法优选PLGA-Cre-NPs的制备工艺。利用膜透析法考察PLGA-Cre-NPs的体外释药规律。结果：PLGA-Cre-NPs的最佳制备工艺为有机相与水相体积比（3：10），丙酮-无水乙醇（8：2），PLGA投入量90 mg。PLGA-Cre-NPs的包封率（84.69±2.54）%，粒径（155.3±14.2）nm，PDI=0.095±0.018，扫描电镜显示其呈规则球形结构。PLGA-Cre-NPs体外释放包括速释和缓释2个阶段，0~24 h符合Weibull方程，24~168 h符合Higuchi方程；半衰期18.06 h，168 h时累计释放率达78.77%。结论：优选的工艺条件稳定可行。制得的PLGA-Cre-NPs包封率较高、粒径均匀，有望制备成缓释制剂。

Abstract

Objective: To prepare and characterize poly(lactic-co-glycolic acid) (PLGA)-crebanine nanoparticles (PLGA-Cre-NPs)

and evaluate its in vitro release. Method: PLGA-Cre-NPs was prepared by emulsion-solvent diffusion method with PLGA as carrier material.Central composite design-response surface methodology was applied to optimize the preparation procedure of the nanoparticles based on the evaluation indexes of encapsulation rate

particle size and polydispersity index (PDI).The in vitro release kinetics of the nanoparticles was investigated by dynamic dialysis system. Result: The optimized preparation procedure was as follows:volume of organic phase-aqueous phase of 3:10

acetone-ethanol (8:2)

PLGA amount of 90 mg.The encapsulation rate of PLGA-Cre-NPs was (84.69±2.54)% with the particle size of (155.3±14.2) nm and PDI of 0.095±0.018

and it showed a regular spherical structure by scanning electron microscopy.Meanwhile

the release profile of PLGA-Cre-NPs could be well described by two phase dynamic equation

0-24 h was closer to Weibull equation

24-168 h was closer to Higuchi equation

and its half life (t1/2) was 18.06 h

the cumulative release rate was 78.77% at 168 h. Conclusion: PLGA-Cre-NPs has high encapsulation rate and uniform size

which will be expected to become a sustained-release preparation.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Folic Acid-modified Crebanine Polyethylene Glycol-polylactic Acid Hydroxyacetic Acid Copolymer Nanoparticles Combined with Ultrasonic Irradiation on Subcutaneous Tumor Growth of Liver Cancer in Mice

Optimization of Formulation of Erhuangsan Bletillae Rhizoma Gelatin Sustained Release Double-layer Membrane by Central Composite Design-response Surface Methodology

Optimization of Prescription of Lycii Fructus Polysaccharide Buccal Tablets by Central Composite Design-response Surface Methodology and Investigation of Its Immunomodulatory Effect

Optimization of Formulation of Co-loaded Docetaxel and Gambogic Acid Albumin Nanoparticles and Evaluation of Its Quality

Related Author

PAN Rui

TANG Junze

ZHANG Hailiang

YU Kun

ZHAO Xiaoyu

CHENG Xin

Yan-hong WANG

Liu YANG

Related Institution

College of Traditional Chinese Medicine，Yunnan Provincial Key Laboratory of Research on External Drug Delivery System and Preparation Technology in Universities，Yunnan Key Laboratory of Sustainable Utilization of Southern Medicine，Yunnan Key Laboratory of Dai and Yi Medicines， Yunnan University of Chinese Medicine

School of Pharmacy, Heilongjiang University of Chinese Medicine

First Affiliated Hospital, Heilongjiang University of Chinese Medicine

Heilongjiang University of Chinese Medicine

Pharmacy College, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization of Chinese Herbal Medicine, Ministry of Education, Key Laboratory of Systematic Research, Development and Utilization of Chinese Medicine Resources in Sichuan Province, Key Laboratory Breeding Base of Co-founded by Sichuan Province and Ministry of Science and Technology

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰